Month: September 2022

Subsidiary of Hepsor AS acquires a property in Riga for development of 40-apartment residential building

Written by Customer Service on September 5, 2022. Posted in Public Companies.

Hepsor JG SIA, a subsidiary of Hepsor AS, signed a sale-purchase agreement on 1 September 2022, for acquiring a property in Jurmala Gatve Street, Imanta district, Riga. The property will accommodate a three-storey A-energy class residential building with 40 apartments and sellable area of approximately 2,500 m2. According to Henri Laks, member of the Management Board of Hepsor AS, the location of the property in the immediate vicinity of the Anninmuiža park, and the A-energy class of the planned building support the Group’s concept of green thinking. Construction of the new development project is expected to start at the end of 2023. Additional information: Hepsor has four residential development projects in Latvia in various stages. All 18 apartments in the Baložu 9 development project, completed this year, have been handed over...

Enedo Oyj’s Board of Directors’ Statement on Inission AB’s Mandatory Public Tender Offer for Enedo Oyj’s Shares

Written by Customer Service on September 5, 2022. Posted in Public Companies.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, SOUTH AFRICA, SINGAPORE, JAPAN, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL Enedo Oyj’s Board of Directors’ Statement on Inission AB’s Mandatory Public Tender Offer for Enedo Oyj’s Shares Inission AB (“Inission” or the “Offeror”) and Enedo Oyj (“Enedo” or the “Company”) have announced in stock exchange releases dated on August 1, 2022 that Inission will make a mandatory purchase offer for all of Enedo’s issued and outstanding shares (“Tender Offer”). The board of directors of Enedo has on September 5, 2022 decided to issue the following statement on the Tender Offer as required...

AS PRFOODS NOTICE OF NOTEHOLDERS’ MEETING

Written by Customer Service on September 5, 2022. Posted in Public Companies.

AS PRFOODS NOTICE OF NOTEHOLDERS’ MEETING AS PRFoods (registry code 11560713, registered address at Pärnu mnt 141, 11314 Tallinn, Estonia; “PRFoods”) hereby notifies persons holding the notes (the “Noteholders”) of the Issuer, due on 22 January 2025 and bearing ISIN code EE3300001577 (the “Notes”), issued under the Terms and Conditions of Secured Note Issue of AS PRFoods dated 14 January 2020 (which have been amended on 25 February 2020 and 25 February 2022) (the “Terms”), of convening a meeting of Noteholders (the “Meeting”). The Meeting will be held on 20.09.2022 at 9:00 (EET) at the offices of Advokaadibüroo COBALT OÜ, address Estonia pst 19 / Tatari tn 1, 10116 Tallinn (Kawe City). Registration for the Meeting will be open at the venue of the Meeting from 8:00 to 8:45 (EET). BACKGROUND PRFoods hereby convenes the Noteholders’...

Shell Plc Second Quarter 2022 Euro and GBP Equivalent Dividend Payments

Written by Customer Service on September 5, 2022. Posted in Dividend Reports And Estimates.

September 5, 2022 The Board of Shell plc (“Shell”) today announced the pounds sterling and euro equivalent dividend payments in respect of the second quarter 2022 interim dividend, which was announced on July 28, 2022 at US$0.25 per ordinary share. Shareholders have been able to elect to receive their dividends in US dollars, euros or pounds sterling. Holders of ordinary shares who have validly submitted US dollars, euros or pounds sterling currency elections by August 26, 2022 will be entitled to a dividend of US$0.25, €0.2499 or 21.57p per ordinary share, respectively. Absent any valid election to the contrary, persons holding their ordinary shares through Euroclear Nederland will receive their dividends in euros at the euro rate per ordinary share shown above. Absent any valid election to the contrary, shareholders (both holding...

Press Release: Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children aged 6 to 11 years with moderate-to-severe asthma

Written by Customer Service on September 5, 2022. Posted in Public Companies.

Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children aged 6 to 11 years with moderate-to-severe asthmaResults from the longest global Phase 3 open-label extension trial in this age group in asthma show sustained improvement in lung function, low rate of asthma attacks and a consistent safety profile for up to two years Data reinforce well-established efficacy and safety profile of Dupixent across age groupsParis and Tarrytown, N.Y. September 5, 2022. Results from a Phase 3 open-label extension trial demonstrated the efficacy and safety profile of Dupixent® (dupilumab) as a maintenance therapy when added to other asthma medications was consistent for up to two years in children aged 6 to 11 years with uncontrolled moderate-to-severe asthma with evidence of...

Tallinna Sadam Investor Day “In the winds of the future” 14.09.2022

Written by Customer Service on September 5, 2022. Posted in Public Companies.

Tallinna Sadam invites its current and future shareholders and other interested parties to the Investor Day “In the winds of the future”, which will take place on September 14 at 16.00 Estonian time in the cruise terminal at the Tallinn Old City Harbour. This time we will focus primarily on growth opportunities related to energy and offshore wind farms. Valdo Kalm and Andrus Ait, members of the management board of Tallinna Sadam, will introduce the company, give an overview of the financial results and future plans. Chief commercial officer Margus Vihman talks in more detail about new business projects and growth opportunities of Tallinna Sadam in the field of energy, and Ülo Eero, manager of the subsidiary TS Shipping, introduces the business opportunities of construction and maintenance of offshore wind farms from the perspective of...

Orion recalls Devisol Salmiakki dietary supplement from consumers

Written by Customer Service on September 5, 2022. Posted in Public Companies.

Devisol_Salmiakki_20mikrog_200tabl Devisol_Salmiakki_20mikrog_200tablDevisol_Salmiakki_20mikrog_230tabl Devisol_Salmiakki_20mikrog_230tablORION CORPORATION PRESS RELEASE 5 SEPTEMBER 2022 AT 8.00 EEST Orion recalls Devisol Salmiakki dietary supplement from consumers Orion is recalling all Devisol Salmiakki dietary supplement packages from consumers due to excessive levels of matrine in the product. Devisol Salmiakki has been on sale in Finland only starting from December 2021. Consumers are requested to return both opened and unopened Devisol Salmiakki products to the nearest pharmacy at the latest on 13 October 2022. The products will be reimbursed for the consumers. Empty packages or free samples will not be reimbursed. The recall does not concern Orion’s other Devisol products. The recall...

Press Release: Evolution of the Board of Directors

Written by Customer Service on September 5, 2022. Posted in Public Companies.

Evolution of the Board of Directors Paris, September 5, 2022. The Board of Directors of Sanofi met on September 2, 2022 and unanimously appointed Frédéric Oudéa as ‘Censeur’ (non-voting member) of the Board with immediate effect. The appointment of Frédéric Oudéa as a director will be submitted for approval at the next Annual General Meeting. Following this Shareholders’ Meeting, a proposal will be made to the Board of Directors of Sanofi to appoint Frédéric Oudéa as non-executive Chairman of the Board, replacing Serge Weinberg whose term of office will have expired. Frédéric Oudéa has announced that he will leave his position as CEO and Director of Société Générale in May 2023. Serge WeinbergChairmain of Sanofi“I am delighted that Frédéric Oudéa has agreed to join the Board of Directors as ‘Censeur’ and, if the General Meeting...

Bone Therapeutics to host Extraordinary General Meeting on 05 October 2022

Written by Customer Service on September 5, 2022. Posted in Public Companies.

REGULATED INFORMATIONAs a result of a technical error in the publication dated August 26, 2022, the Board of Directors has decided to reconvene the extraordinary general meeting originally scheduled to be held on September 26, 202 and to postpone it to October 5, 2022 Preliminary documents for the Extraordinary General Meeting have been made available on company’s website Mont-Saint-Guibert, Belgium, 05 September 2022, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics, invites its shareholders and the holders of registered subscription rights and registered convertible bonds of the Company to the extraordinary general meeting to be held on Wednesday 05 October 2022 as from 02:00 pm CEST, at Avenue Lloyd George 11, 1000 Brussels, Belgium. The notice...

VEON’s Banglalink Wins Top Speed Prize for Third Year in a Row

Written by Customer Service on September 5, 2022. Posted in Public Companies.

Bangalink Wins Ookla® Speedtest Award™ for fastest mobile network in Bangladesh for third consecutive yearAmsterdam, 2 September 2022: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and services, today announces that its operating company in Bangladesh, Banglalink, has received the award for the fastest mobile network in Bangladesh for the third year running. Ookla’s Speedtest report found Banglalink to have a Speed Score™ of 21.56; crowning Banglalink as the leading provider of high-speed internet in Bangladesh. Banglalink has recently rolled out more than 3000 sites across the country and has doubled its spectrum holding through the acquisition of a 40 MHz spectrum, while also recording double-digit revenue growth in Q2, 2022. “VEON is committed to providing...

Month: September 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals